Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neomycine/Metronidazole- vs Rifaximin-based Gut Decolonisation Prior to Colon Surgery: a Randomized Multicenter Trial

NCT07180615 is registered in ClinicalTrials.gov with Universität Luzern as lead sponsor.

NCT NCT07180615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07180615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neomycine/Metronidazole- vs Rifaximin-based Gut Decolonisation Prior to Colon Surgery: a Randomized Multicenter Trial
Lead sponsor
Universität Luzern
Phase
Phase 4
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
June 30, 2029
Enrollment
458 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

colon surgery, surgical site infection, surgical site infections